WO1998008978A1 - Appareil et procede pour la mise en oeuvre d'un sequençage de polymeres nucleotidiques - Google Patents

Appareil et procede pour la mise en oeuvre d'un sequençage de polymeres nucleotidiques

Info

Publication number
WO1998008978A1
WO1998008978A1 PCT/US1997/015056 US9715056W WO9808978A1 WO 1998008978 A1 WO1998008978 A1 WO 1998008978A1 US 9715056 W US9715056 W US 9715056W WO 9808978 A1 WO9808978 A1 WO 9808978A1
Authority
WO
WIPO (PCT)
Prior art keywords
region
sequencing
fragments
sample
dna
Prior art date
Application number
PCT/US1997/015056
Other languages
English (en)
Inventor
Paul Waterhouse
Alexandre M. Izmailov
Henryk Zaleski
Thomas D. Yager
James M. Dunn
James Leushner
May Hui
Marina T. Larson
Original Assignee
Visible Genetics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visible Genetics Inc. filed Critical Visible Genetics Inc.
Priority to AU42365/97A priority Critical patent/AU4236597A/en
Priority to CA002264961A priority patent/CA2264961A1/fr
Priority to EP97940630A priority patent/EP0927268A1/fr
Publication of WO1998008978A1 publication Critical patent/WO1998008978A1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00—Heating or cooling apparatus; Heat insulating devices
    • B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44704—Details; Accessories
    • G01N27/44743—Introducing samples

Definitions

  • This application relates to apparatus for performing DNA sequencing reactions, and in particular to improved apparatus for performing sequencing reaction Protocols making use of thermally stable polymerase enzymes having enhanced capacity to incorporate chain terminating nucleotides during chain termination sequencing reactions.
  • DNA sequencing is generally performed using techniques based on the "chain termination” method described by Sanger et al., Proc. Natl Acad. Sci. (USA) 74 (12): 5463-5467 ( 1977) . Basically, in this process, DNA to be tested is isolated, rendered single stranded, and placed into four vessels.
  • each vessel contains the necessary components to replicate the DNA strand, i.e., a template-dependant DNA polymerase, a short primer molecule complementary to a known region of the DNA to be sequenced, and the standard deoxynucleotide triphosphates (dNTP's) commonly represented by A, C, G and T, in a buffer conducive to hybridization between the primer and the DNA to be sequenced and chain extension of the hybridized primer.
  • each vessel contains a small quantity of one type (i.e., one species) of dideoxynucleotide triphosphate (ddNTP), e.g. dideoxyadenosine triphosphate (ddA).
  • ddNTP dideoxynucleotide triphosphate
  • ddA dideoxyadenosine triphosphate
  • the primer hybridizes to a specific complementary site on the isolated DNA.
  • the primers are then extended, one base at a time to form a new nucleic acid polymer complementary to the isolated pieces of DNA.
  • a dideoxynucleotide triphosphate is incorporated into the extending polymer, this terminates the polymer strand and prevents it from being further extended.
  • a set of extended polymers of specific lengths are formed which are indicative of the positions of the nucleotide corresponding to the dideoxynucleotide in that vessel.
  • These sets of polymers are then evaluated using gel electrophoresis to determine the sequence. Improvements to the original technique described by Sanger et al. have included improvements to the enzyme used to extend the primer chain.
  • Tabor et al. have described enzymes such as T7 DNA polymerase which have increased processivity, and increased levels of incorporation of dideoxynucleotides. (See US Patent No. 4,795,699 and EP-A-0 386 857, which are incorporated herein by reference). More recently, Reeve et al. have described a thermostable enzyme preparation, called ThermoSequenaseTM, with improved qualities for DNA sequencing. Nature 376: 796-797 (1995); EP-A-0 655 506, which is incorporated herein by reference.
  • ThermoSequenaseTM product is used with an amplified DNA sample containing 0.5-2 ⁇ g of single stranded DNA (or 0.5 to 5 ⁇ g of double stranded DNA) into four aliquots, and combining each aliquot with the ThermoSequenaseTM enzyme preparation, one dideoxynucleotide termination mixture containing one ddNTP and all four dNTP's; and one dye-labeled primer which will hybridize to the DNA to be sequenced.
  • EP-A- 0 655 506 further asserts that ThermoSequenaseTM and similar enzymes can be used for amplification reactions.
  • Each of the processes known for determining the sequence of DNA can be preceded by amplification of a selected portion of the genetic material in a sample to enrich the concentration of a region of interest relative to other DNA. For example, it is possible to amplify a selected portion of a gene using a polymerase chain reaction (PCR) as described in U.S. Patents Nos. 4,683,194, 4,683,195 and 4,683,202, which are incorporated herein by reference. This process involves the use of pairs of primers, one for each strand of the duplex
  • Chain extension polymerization (without a chain terminating nucleotide) is then carried out in repetitive cycles to increase the number of copies of the region of interest many times.
  • the amplified poly- nucleotides are then separated from the reaction mixture and used as the starting sample for the sequencing reaction.
  • Gelfand et al. have described a thermostable enzyme, "Taq polymerase,” derived from the organism Thermus aquaticus, which is useful in this amplification process. (See US Patent Nos. 5,352,600 and 5,079,352 which are incorporated herein by reference).
  • Coupled amplification and sequencing for sequencing of DNA.
  • a sample is treated in a first reaction stage with two primers and amplified for a number of cycles to achieve 10,000 to 100,000-fold amplification.
  • a ddNTP is then added during the exponential phase of the amplification reaction, and the reaction is processed for additional thermal cycles to produce chain-terminated sequencing fragments.
  • the CAS process does not achieve the criteria set forth above for an ideal diagnostic assay because it requires an intermediate addition of reagents (the ddNTP reagents). This introduces and opportunity for error or contamination and increases the complexity of any apparatus which would be used for automation.
  • thermocycling apparatus for performing an initial amplification
  • apparatus for performing a sequencing reaction an apparatus for performing a sequencing reaction
  • electrophoresis apparatus for separating the sequencing reaction products.
  • the detection of the sequencing reaction products is performed in real time, and the detection system is incorporated as part of the electrophoresis apparatus.
  • the detection of the sequencing fragments is performed after the separation is completed using a further piece of apparatus.
  • the present invention provides an apparatus and associated sample processing element for performing sequencing of a DNA containing sample, particularly a sample of genomic or other natural abundance DNA.
  • the apparatus comprises
  • thermocycling region for receiving a sample processing element having a thermocycling region, a separation region and a detection region
  • means for regulating the temperature within the thermocycling region of a sample processing element placed within the holder for regulating the temperature within the thermocycling region of a sample processing element placed within the holder
  • thermocycling region means for applying an electric field to the separation region of a sample processing element placed within the holder to cause polynucleotide fragments formed in the thermocycling region to migrate through the separation region from the thermocycling region to the detection region;
  • Sequencing is performed by loading a genomic or natural abundance DNA-containing sample; a thermostable polymerase such as ThermoSequenaseTM which incorporates dideoxynucleotides into an extending nucleic acid polymer at a rate which is no less than about 0.4 times the rate of incorporation of deoxynucleotides; two primers which bind to complementary strands of a target DNA molecule at sites flanking a region of interest; a mixture of nucleotide triphosphates (A, C, G and T) and one dideoxynucleotide triphosphate into the thermocycling region of a sample processing element placed within the apparatus, and processing the combination through multiple cycles of annealing, extension and denaturation to form a mixture of sequencing fragments within the thermocycling region.
  • a thermostable polymerase such as ThermoSequenaseTM which incorporates dideoxynucleotides into an extending nucleic acid polymer at a
  • An electric field is then applied to the sample processing element to cause the sequencing fragments to migrate from the thermocycling region, through the sample processing element and to the detection region. As the fragments pass through the detection region, they are detected and the output signal is analyzed to yield the sequence of the region of interest within the target sequence.
  • FIGS. 1 A and IB show an embodiment of a sample processing element and apparatus in accordance with the invention
  • Fig. 2 shows a further embodiment of the apparatus of the invention
  • Fig. 3 shows a section view through the thermocycling region of an embodiment of a sample processing element in accordance with the invention
  • Fig. 4 shows an embodiment of an apparatus of the invention
  • Fig. 5 shows an embodiment of an apparatus of the invention
  • Fig. 6 shows a further embodiment of a sample processing element in accordance with the invention
  • Fig. 7 shows a thermocycling and concentration chamber useful as part of a sample processing element in accordance with the invention
  • Fig. 8 shows a further embodiment of the invention
  • Fig. 9 shows an embodiment of a thermocycling chamber useful in the present invention.
  • Fig. 10 shows the positioning of a denaturing buffering in an electrophoresis gel forming part of a sample processing element of the invention
  • Figs 1 1 A and 1 1 B show sequencing fragments patterns obtained using
  • Fig. 12 shows a sequencing fragment pattern obtained using ThermoSequenaseTM.
  • the present invention provides an apparatus which helps to exploit the properties of enzymes like ThermoSequenaseTM, namely the ability to incorporate dideoxynucleotides into an extending polynucleotide at a rate which is no less than about 0.4 times the rate of incorporation of deoxynucleotides, to enable sequencing of a nucleic acid polymer from a sample in a single apparatus.
  • ThermoSequenaseTM namely the ability to incorporate dideoxynucleotides into an extending polynucleotide at a rate which is no less than about 0.4 times the rate of incorporation of deoxynucleotides, to enable sequencing of a nucleic acid polymer from a sample in a single apparatus.
  • the apparatus and sample processing element of the invention can be used to analyze any DNA containing sample including samples which have been previously amplified, they are particularly suited for analysis of samples containing natural abundance DNA.
  • a "natural abundance sample” is a sample which has been treated to make DNA in the sample accessible for hybridization with oligonucleotide primers, for example by lysis, centrifugation to remove cellular debris and proteolytic digestion to expose the DNA, but which has not been subjected to a preferential purification or amplification step to increase the amount of target DNA relative to non-target DNA present in the initial sample.
  • the term "natural abundance” does not, however, require the presence of all the DNA from the original sample.
  • a complex sample containing just nuclear DNA, or just mitochondrial DNA or some subfraction of nuclear or mitochondrial DNA obtained by isolation from a tissue sample but not subjected to preferential amplification would be a complex sample containing just nuclear DNA, or just mitochondrial DNA or some subfraction of nuclear or mitochondrial DNA obtained by isolation from a tissue sample but not subjected to preferential amplification.
  • natural abundance sample within the meaning of that term in the specification and claims of this application.
  • the term “natural abundance” would also include a DNA sample prepared by conversion, for example by reverse transcription, of a total mRN A preparation or the genome of an RNA virus to cDNA; DNA isolated from an individual bacterial colony growing on a plate or from an enriched bacterial culture; and a viral DNA preparation where substantially the entire viral genome is isolated.
  • the term "natural abundance” does not encompass a sample in which the isolated DNA is not a complex combination of DNA molecules, and thus would not encompass, for example, a purified plasmid preparation containing only a single species of plasmid.
  • thermocycling region means for regulating the temperature within the thermocycling region of a sample processing element placed within the holder;
  • the sample processing element of the present invention can be considered as three functional regions: a thermocycling region, a separation region and a detection region. As will be apparent from the various embodiments discussed below, these regions can be parts of integrated device, or can be separate component parts.
  • the thermocycling region is a chamber in which the chemical reactants necessary for forming sequencing fragments directly from DNA are placed and exposed to cycles of temperature effective to promote denaturation and annealing/extension. This can be achieved by varying the temperature of the entire thermocycling region or by creating discrete temperature bands within the region.
  • the separation region of the sample processing element can be any type of separation matrix that is effective to separate DNA sequencing fragments on the basis of fragment size.
  • the detection region of the sample processing element may be a contiguous part of the separation region, distinguishable only by the fact that detection of separated fragments occurs in this region.
  • the detection region may also be a discrete part of the sample processing element, however, in which fragments are detected after leaving the separation region.
  • Figs. 1 A and IB show a first embodiment of the sample processing element and apparatus of the present invention.
  • the sample processing element is a separation matrix such as an electrophoresis gel 10, optionally supported by a substrate 1 1.
  • the electrophoresis gel 10 has three functional regions: a thermocycling region 101, a separation region 102 and a detection region 103. Within the thermocycling region 101 are a plurality of wells 12 into which the reaction mixtures for the production of sequencing fragments are placed.
  • a sample processing element formed from a polyacrylamide gel 10 and substrate 1 1 are placed within a holder 13 of an apparatus as shown in Fig. IB.
  • the holder 13 positions the polyacrylamide gel 10 such that the wells 12 are in alignment with a temperature regulating element, for example a Peltier heating and cooling device 14 powered via leads 1 14 and 1 14'.
  • the holder 13 also positions the sample processing element with respect to electrodes 15 and 16 which are used to generate the electrophoretic field with the polyacrylamide gel 10, and places the detection zone 103 of the sample processing element in alignment with a light source 17 for supplying excitation suitable for excitation Of fluorescent labels on the sequencing fragments and an array of detectors 18 for detecting emission from the fluorescent labels.
  • Regulating the temperature of the thermal cycling region can be achieved by a variety of methods.
  • One method, illustrated in Fig. IB shows the use of a Peltier device 14 for heating and cooling.
  • a preferred apparatus employs a relatively large cooling sink 20 in the thermal cycling region 101 as shown in Fig. 2.
  • the sink temperature is maintained below the minimum cycling temperature, at 4 to 35° C, preferably about 25 °C.
  • the temperature of reagents with the thermocycling region 101 should be maintained within approximately +/- 0.5 °C of the desired temperature.
  • the control of the radiation intensity therefore requires careful consideration.
  • a variety of detectors may be used to determine the sample temperature. Temperature sensitive films using liquid crystals (Edmund Scientific Co., Barrington, NJ) can determine temperature to within +/- 0.1 C C. These films could be placed beside or underneath the sample wells 12, and so provide a precise method of temperature detection. Alternatively, since the refractive index of the sample will change with temperature, detectors of refractive index may be employed. Further options include temperature sensitive dyes added directly to the sample. Detection of electrical capacitance which changes with the temperature of the solution can also be used. In all the above cases, the detectors can be linked to microprocessors which change the intensity of the radiation source to obtain the desired temperature.
  • the apparatus of the invention also includes means for applying an electric field to the separation region of the sample processing element.
  • This can be in the form of solution electrodes, disposed at either end of the sample processing element.
  • the electrophoresis gel within the sample processing element is immersed in a buffer in two wells, each of which contains an electrode which is connected to a power supply for generating the electrophoretic field.
  • the electrodes can be printed on the surface of the sample processing element.
  • Printed electrodes can be formed from a variety of materials, including indium tin oxide (ITO) or platinum, In either case, an electric field is generated between the electrodes of sufficient magnitude to cause the sequencing fragment to migrate from through the separation region 102 where they are separated into bands based upon the size the fragment.
  • ITO indium tin oxide
  • platinum platinum
  • the sequencing fragments are separated by electrophoresis through the separation region 102 of the sample processing element, they are detected in the detection region 103.
  • the type of detection system employed will depend on the type of label incorporated into the sequencing fragments.
  • the preferred type of label will be a fluorescent label, in which case detection of sequencing fragments can be achieved using fluorescence detection means, as described for example in US Patent Application Serial No. 08/353,932, which is incorporated herein by reference.
  • fluorescence detection means as described for example in US Patent Application Serial No. 08/353,932, which is incorporated herein by reference.
  • a detection scheme is shown generally in Fig. IB, in which a radiation source 17 provides excitation energy to fluorophores in the sequencing fragments which are detected by an array of fluorescence detectors 18.
  • various types of light sources producing light of an appropriate wavelength for excitation of the fluorophores may be employed, including lasers, laser diodes, and light-emitting diodes.
  • the light may be split into individual excitation beamlets for excitation of multiple detection sites (corresponding to the lanes of the gel) within the detection region using optical fibers, diffractions gratings, a spot array generation grating or other optical components.
  • a plurality of light sources one for each detection site can be used.
  • the apparatus may provide light of several different wavelengths to the detection site, either through the use of multiple light sources or using optical filters.
  • the array of detectors 18 may provide a separate detector for each detection site within the detection region 103, or one detector may be aligned to collect light from several adjacent detection site. In the latter case, the excitation light beams to the adjacent sites are suitably applied to a temporally staggered fashion so that emission from the detection sites can be distinguished.
  • fluorescence labeling and detection is the preferred method of practicing the invention, other types of labeling and detection can be used as well.
  • a chromophore or a chromogenic label can be used with a photometric detection system, or a strongly chiral label could be used with a polarization detection system as described in US
  • Patent Application Serial No. 08/387,272 which is incorporated herein by reference.
  • the output of the detector array is an electrical signal representing the position of one more bases in the target sequence.
  • This signal is preferably transferred to a data processing apparatus, such as a micro or minicomputer for data alignment and base calling.
  • Data alignment and base calling is preferably performed using the techniques described in US Patent Applications Nos. 08/497,202 and 08/670,534 which are incorporated herein by reference.
  • thermocycling region a thermocycling region
  • separation region a separation region
  • detection region a detection region
  • the basic component of the sample processing element of the invention is a polyacrylamide gel 10, optionally supported by a substrate 1 1 or a pair of substrates.
  • the thermocycling region 101 is different from the separation and detection regions 102 and 103 (which are structurally indistinguishable from one another) by virtue of the wells 12 formed in the polyacrylamide gel to receive the sequencing reaction mixture.
  • the wells need to hold this reaction mixture with sufficient integrity for the duration of the thermal cycling reaction. This may take up to 2 hours in some cases, although preferably it would be completed in under 30 minutes.
  • a cycling chamber insert, 30, may be employed, as in Fig. 3.
  • This glass or plastic chamber insert 30 acts as liner to prevent reactant from dissolving into the buffer of the gel 32 surrounding the chamber 12.
  • Each insert has walls but no bottom, with the substrate 31 serving as a floor.
  • the outside of the chamber insert 30 may be in direct contact with the gel 32, if, for example, the insert 30 is put in place before the polyacrylamide gel is cast.
  • the chamber insert 30 receives the sample and keeps it concentrated.
  • the reactants may be layered with an oil.
  • the chambers may have individual caps which are heated to keep water from condensing on the top of the chamber.
  • the chamber insert 30 may be disposable. If it does not have an internal valve or removable wall to release the sample after thermal cycling it can simply be removed from the gel prior to electrophoresis.
  • a chamber insert material that dissolves after the reactions are completed could also be used. In the end, the reaction products would be conveniently situated in the wells, ready for electrophoretic analysis.
  • An alternative method to release reaction products after the reaction is to use a viscosity trap.
  • This method uses a wax, oil or glycerol which acts as a solid barrier to diffusion at a cool temperature, but which will allow migration of sample when warmed or melted.
  • a very small amount of barrier material can be kept sufficiently cool to prevent the heated reaction products from leaking from the thermocycling region.
  • the temperature of the trap is raised to allow diffusion of the reaction products out of the thermocycling region.
  • Figs. 4 and 5 illustrate alternative designs for the thermocycling region of the sample processing element where the apparatus provides fixed temperature heat zones are used and the DNA sample migrate from one temperature site to the next, in sequence.
  • the migration may be induced by electrophoresis, a thermal capillary pump (see Burns et al. 1991.
  • temperature regulating elements 400, 401 and 402. These temperature regulating elements may be Peltier devices, heat exchangers, or combinations of heat sinks and radiant heaters as disclosed above.
  • a series of reversible electrodes 40, 41 , 42 and 43 are employed to move DNA back and forth between the temperature regions within a buffer reservoir. For example, a sample and accompanying reaction mixture may be initially be deposited in denaturation region D and treated for an initial denaturation time at denaturation temperature.
  • Electrodes 40 and 43 are then activated to cause the DNA in the sample to migrate from the denaturation region D to the annealing region A, after which time the electric field is either turned off or electrodes 42 and 43 are turned on with oscillating polarity to maintain it within the region.
  • the DNA is allowed to rest in the annealing region A for a period of time corresponding to the desired annealing time, after which time electrodes 41 and 43 are activated to cause the annealed DNA to migrate to the extension region E and then turned off. After the desired period of time at the extension temperature, electrodes 40 and 42 are activated to cause the DNA to migrate back to the denaturation region D.
  • This cycle of activating and deactivating electrode pairs is repeated for as many cycles as is necessary to produce a detectable amount of sequencing fragments. Then electrodes 15 and 16 are activated to cause the sequencing fragments to migrate through the separation region 102, to the detection region 103.
  • DNA can be bound to magnetic beads, such as Dynal beads, and moved from one temperature region to the next by an electromagnet.
  • a denatured DNA-containing sample is loaded in an annealing region, and allowed to hybridize with primers.
  • An electromagnet is then turned on to move the DNA to the extension region.
  • the electromagnet may be located under the extension region, or may be a "moving" magnet which starts at the annealing region and moves to the extension region. "Moving” in this case can refer to physical movement of an electromagnet from one region to the next, or can be simulated through the use of several magnets which are activated in sequence to create the same effect.
  • the electro- magnet may be switched off or maintained, at a low field strength to limit diffusion of the DNA.
  • the hybridized primers and template are exposed to all reagents, including enzymes, that are needed for primer extension/chain termination.
  • the enzymes may be linked to a solid support and fixed at the extension site to prevent diffusion in the sample processing element.
  • the DNA is magnetically transported to the denaturing region to separate the DNA strands.
  • the separated strands are magnetically transported back to the annealing region.
  • a fresh supply of some reagents may be required to allow for continued reactions. These reagents may be supplied by a continuous drip of fresh reagents.
  • Fig. 5 shows a variation of the apparatus shown in Fig. 4 in which one circular array of heat pads are disposed within the thermocycling region 101 for each sample. Each heating zone D (denaturation), A (annealing) and E (extension) is separately heated and maintained within +/- 0.5 °C. Aqueous buffer covers the entire unit. Again, some reagents maybe immobilized or added to specific regions during the thermocycling.
  • the reaction mixture is loaded and contained over the heat pads in the thermocycling zone 101, and DNA is drawn towards the denaturation zone D where the temperature is maintained at the denaturation temperature (i.e., 94°C) by activation of electrodes 501/502 and 505/503.
  • electrodes 502 and 503 are activated to draw the sample to the annealing region A.
  • electrodes 504 and 505, are activated to draw the DNA to the extension phase temperature region E.
  • the cycle is completed by activating electrodes 506 and 501, to draw the DNA to the denaturing region D of the device.
  • the sample is denatured one last time, then separated through the separation matrix upon the activation of electrodes 15 and 16.
  • a non-thermostable polymerase enzyme can be used if it can be successfully contained within the extension region E. This can be accomplished by immobilization of the enzyme in the extension region or by placing semipermeable membranes which restrict the passage of polymerase enzyme but not the relatively smaller DNA molecules around the extension region E.
  • thermocycling region is a discrete thermocycling and concentration manifold 60 which is separable from rather than integral with the gel portion of the sample processing element.
  • the manifold 60 is made up of an array of individual thermocycling and sample concentrating chambers 70, a single one of which is shown in Fig. 7.
  • the manifold 60 has a temperature regulating element 61 disposed in contact therewith for regulating the temperature of materials within the thermocycling and sample concentrating chambers 70.
  • the manifold 60 fits directly onto the top of an electrophoresis gel, for example a Visible Genetics Inc. MicroCelTM Cassette, (50 micron thick electrophoresis slab gel) of the type described in US Patent Application No. 08/332,557 and International Patent Publication No. W096/13717, which are incorporated herein by reference.
  • This gel has a top substrate 61 and a bottom substrate 62 surrounding a very thin gel 63.
  • the top substrate 61 has a free beveled edge 64 which receives the manifold 60.
  • the manifold 60 is suitably made of a thermally conductive material to facilitate temperature regulation.
  • the manifold may be disposable, or it may include disposable inserts.
  • a sequencing reaction mixture is loaded into each chamber 201 of the manifold 60, and the temperature is then cycled as required to produce sequencing fragments.
  • the amplified DNA in the sample is then electrophoretically concentrated and loaded onto the gel 63.
  • each sample concentrating and loading chamber consists of a large rectangular channel 201 which functions as the thermocycling chamber attached at right angles to a second smaller rectangular channel 202.
  • the upper face of the large rectangular channel 201 is open, and receives a volume (for example 100 nL of unconcentrated sample containing a DNA mixture to be separated.
  • the lower face of the smaller rectangular channel 202 is also open and releases the concentrated sample (approx 1 pL) into one of the functional channels of the DNA sequencing gel 63.
  • sample loaded into the top of the large channel 201 is electrophoresed using a field generated between electrodes 205a and 205b.
  • the DNA is collected on a semipermeable membrane 204a which has a molecular weight cutoff low enough to prevent passage of the DNA but which permits passage of the solvent from the sample, thereby effecting a first concentration of the sample on the semi-permeable membrane 204a.
  • a second set of electrodes 206a and 206b are turned on to generate cause the concentrated sample to migrate in a direction perpendicular to the original migration from the semipermeable membrane 204a into the small channel 202.
  • a second semipermeable membrane 204b retains sample within the small channel 202 while permitting passage of solvent.
  • a third electrode set 207a and 207b is used to electrophorese the doubly-concentrated sample from the small channel 202 into one of the DNA sequencing gel 63.
  • a valve can be used in lieu of the electric fields to dispense the fragments onto the gel, but this device does not provide the reduction in sample volume of the device shown in Fig. 7.
  • Fig. 8 illustrates an alternative embodiment where the manifold 60 is thermal cycled separately from the gel cassette in a separate heating/cooling block 802, and then clipped onto the gel cassette 800 immediately prior to loading into the electrophoresis gel, 63. This design prevents the cassette itself from being exposed to thermal cycling conditions, which may prove detrimental to the effectiveness of the sample processing element.
  • Fig. 9 shows an alternative design for a thermocycling chamber which can be used in placo of or in combination with the loading/concentration manifold of Fig. 7.
  • a capillary tube 91 is filled partway with a viscous liquid 92a such as 50% glycerol or 50% sucrose in buffer, then with the PCR solution 93 containing primers, buffer, dNTPs, genomic DNA substrate, ddNTPs and ThermoSequenaseTM enzyme, and then again with further buffered viscous liquid,
  • a viscous liquid 92a such as 50% glycerol or 50% sucrose in buffer
  • the diameter of the capillary is small enough that surface tension holds the different liquid layers without mixing.
  • the two viscous layers when brought to a low temperature, will act as a viscosity trap 81, to confine the PCR to a small volume.
  • the capillary is placed snugly within a channel in a thermal cycling system, 94, such as a block or fluid based heating/ cooling system.
  • the ends of the capillary are inserted into buffer chambers 95 to.prevent evaporation.
  • the thermocycling system is designed to maintain a temperature of approximately 0°C at the two viscosity traps, 92a and 92b, and also to provide temperature cycling (e.g. 94-55-72 °C) at the central PCR solution, 93.
  • the capillary is removed from the thermal cycling system and the contents loaded onto a separation matrix.
  • the capillary can be inserted through a hole or notch in the top substrate of an electrophoresis gel holder, or can be expelled into conventional sample loading slots of an electrophoresis gel, or can be expelled into a chamber of a loader/concentrator of the type shown in Fig. 7.
  • the viscosity trap is first opened by warming the capillary. DNA can be moved out of the capillary and onto the separation matrix using an electric field, or (particularly in the case where the loader is used) can be simply expel led along with the trap components using mild air pressure.
  • the reaction mixture may optionally be drawn through a denaturing "loading buffer" just prior to its entrance in the gel, as illustrated in Fig. 10.
  • the entrance to gel 901 , between the substrates 902, is layered with a thin wash of denaturing/stop buffer (50- 100 mM formamide, plus dyes, etc), 903.
  • the lower end of the thermocycling and concentrating chamber 60 is placed in the buffer 903 leaving a short gap for sample to traverse between the device and the gel, 901.
  • Electrodes 904 and 905 which are printed on the inside face of the substrate 902 can be switched on to draw the sample through the buffer layer.
  • the detection region of the sample processing element of the invention may simply be a continuous portion of the separation region, distinguished only by its function. If desired, however, the detection region can have structure specifically adapted to facilitate detection of the separated sequencing fragments as they pass through the detection region.
  • one substrate can be made with a thin region localized in the detection region to create a window for monitoring the detection region with decreased interference from the substrate.
  • Such substrates can be formed by molding a contiguous substrate into the desired shape, or by affixing blocks of thicker materials onto a continuous thin substrate.: In the latter case, the blocks 71 of thicker material may also be formed from absorbing, non-fluorescing materials to further reduce background fluorescence.
  • the apparatus and sample processing element of the invention are utilized in the method of the invention to sequence DNA, for example the DNA found in natural abundance DNA samples.
  • thermostable polymerase enzyme which incorporates dideoxynucleotides into an extending polynucleotide at a rate which is no less than about 0.4 times the rate of incorporation of deoxynucleotides, a natural abundance DNA-containing sample, two primers flanking the region of DNA to be sequenced, each primer binding to a different strand of duplex DNA, and other reagents for performing an enzyme-catalyzed primer extension reaction are combined in the thermocycling region of a sample processing element.
  • the sample processing element is then placed in the apparatus of the invention and processed through sufficient cycles to produce a detectable amount of sequencing fragments.
  • An electric field is then generated to cause the sequencing fragments to migrate through the separation region of the sample processing element, arid thereby be separate into discrete bands on the basis of the size of the fragments. These bands are then detected as they pass through the detection region.
  • a key factor in successfully performing the method of the invention is the utilization of ThermoSequenaseTM or a comparable enzyme as the thermostable polymerase in the reaction mixture.
  • Such an enzyme is characterized by a high affinity for incorporating dideoxynucleo- tides into the extending nucleotide chain.
  • ThermoSequenaseTM is known to favor the incorporation of dideoxynucleotides.
  • the polymerase used should be one which incorporates dideoxynucleotides into an extending nucleic acid polymer at a rate which is no less than about 0.4 times the rate of incorporation of deoxynucleotides.
  • Figs. 11A, 11B and 12 illustrate the importance of this characteristic of the polymerase enzyme employed.
  • Figs. 11 A and 12 shows a sequencing data trace for an actual patient sample of genomic DNA which was obtained using ThermoSequenaseTM and primers effective to amplify exon 2 of the Von Hippel-Lindau gene in a process according to the invention. Large, well-defined peaks corresponding to the termination fragments were obtained which made sequence evaluation of the sample very straight- forward, tn addition, the peaks for homozygous peaks are all approximately the same size, and are readily distinguishable from peaks for heterozygous locations. This result was obtained performing the test in a single reaction vessel, with a single unaugmented reaction mixture, in a total of 45 thermal cycles. Comparable results could be obtained using fewer reasctions cycles, for example 35 cycles.
  • Fig. 1 IB shows the trace obtained when a combination of Vent and SequithermTM was used instead of ThermoSequenaseTM for a total of 45 cycles.
  • the peaks for the termination fragments are much smaller and less well defined.
  • the peaks are quite variable in height and did not permit identification of heterozygous peaks based on peak height. Performing the same experiment using Taq polymerase resulted in a data trace that contained no usable peaks.
  • the two primers used directly produce the sequencing fragments which are analyzed to determine the sequence of the DNA in the sample.
  • at least one of the primers is advantageously labeled with a detectable label such as a radiolabel, a fluorophore, a chromophore, a fluorogenic or chromogenic label, or any other label which can facilitate the detection of the sequencing fragments produced in the reaction.
  • a detectable label such as a radiolabel, a fluorophore, a chromophore, a fluorogenic or chromogenic label, or any other label which can facilitate the detection of the sequencing fragments produced in the reaction.
  • Some full length product (the product spanning from one primer to the other) will also be produced and will be detected during sequencing and may be a substantial band relative to any of the individual truncation products. To avoid losing information due to the size of this band, it may be advantageous to use relatively long primers, for example a 20-25 mer such that the difference in length between the full
  • the second primer can be labeled with a second detectable label, preferably different in characteristics from the first label.
  • the primers can be labeled with two different fluorophores as in the process described by Wiemann et al., "Simultaneous On-Line DNA Sequencing on Both Stands with Two Fluorescent Dyes," Anal, Biochem 224- 1 17-121 (1995).
  • Analysis of the fragments labeled with the two different labels can be accomplished by loading aliquots of the reaction mixture onto two different electrophoresis lanes which are evaluated for different label types or by loading the product mixture onto one lane in a multi-dye sequencer which has the ability to evaluate several labels in a single instrument.
  • Natural abundance DNA can be prepared from blood or tissue samples by any of a number of techniques, including salt precipitation or standard SDS-proteinase K-phenol extraction. Natural abundance DNA can also be prepared using kits, for example the Gentra Pure Gene DNA Isolation Kit.

Abstract

Cette invention concerne un appareil conçu pour traiter des échantillons contenant de l'ADN en vue de la production d'un mélange de fragments de séquençage. Ledit appareil comporte un élément de traitement des échantillons possédant une région de thermocyclage comprenant une ou plusieurs chambres conçues pour recevoir un mélange réactionnel de séquençage d'ADN et pour former à partir dudit mélange des fragments de séquençage, une région de séparation comportant une matrice servant à séparer les fragments de séquençage formés dans la région de thermocyclage, une région de détection permettant la détection des fragments de séquençage séparés, et un organe de régulation de la température, disposé dans la région de thermocyclage de l'élément de traitement des échantillons, servant à produire une pluralité de cycles thermiques, chacun de ces cycles comportant au moins une phase de dénaturation et une phase d'extension. On peut placer ledit appareil de traitement des échantillons dans un support associé d'une part, à un organe servant à appliquer un champ électrique à la région de séparation de l'appareil de traitement d'échantillons placé à l'intérieur dudit support de manière à provoquer la migration des fragments de séquençage des polynucléotides à travers la région de séparation, de la région de thermocyclage vers la région de détection, et d'autre part à un organe de détection des fragments de polynucléotides au sein de la région de détection de l'appareil de traitement des échantillons placé à l'intérieur dudit support.
PCT/US1997/015056 1996-08-27 1997-08-27 Appareil et procede pour la mise en oeuvre d'un sequençage de polymeres nucleotidiques WO1998008978A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU42365/97A AU4236597A (en) 1996-08-27 1997-08-27 Apparatus and method for performing sequencing of nucleic acid polymers
CA002264961A CA2264961A1 (fr) 1996-08-27 1997-08-27 Appareil et procede pour la mise en oeuvre d'un sequencage de polymeres nucleotidiques
EP97940630A EP0927268A1 (fr) 1996-08-27 1997-08-27 Appareil et procede pour la mise en oeuvre d'un sequen age de polymeres nucleotidiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70371096A 1996-08-27 1996-08-27
US08/703,710 1996-08-27

Publications (1)

Publication Number Publication Date
WO1998008978A1 true WO1998008978A1 (fr) 1998-03-05

Family

ID=24826465

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/015056 WO1998008978A1 (fr) 1996-08-27 1997-08-27 Appareil et procede pour la mise en oeuvre d'un sequençage de polymeres nucleotidiques

Country Status (4)

Country Link
EP (1) EP0927268A1 (fr)
AU (1) AU4236597A (fr)
CA (1) CA2264961A1 (fr)
WO (1) WO1998008978A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795426A1 (fr) * 1999-06-22 2000-12-29 Commissariat Energie Atomique Support d'analyse biologique a amplification
WO2005106449A1 (fr) * 2004-04-21 2005-11-10 Beckman Coulter, Inc. Dispositif d'analyse dote d'une unite de regulation de la temperature perfectionnee
EP1642647A1 (fr) * 2004-09-30 2006-04-05 Roche Diagnostics GmbH Dispositif et proeédé pour regler la temperature d'un liquide
EP1642648A1 (fr) * 2004-09-30 2006-04-05 Roche Diagnostics GmbH Dispositif et proeédé pour regler la temperature d'un liquide
EP1733218A2 (fr) * 2004-03-15 2006-12-20 D.N.R. - Imaging Systems Ltd Procede et systeme pour controler un processus de separation des matieres tel qu'un processus d'electrophorese dans un echantillon
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US7645596B2 (en) 1998-05-01 2010-01-12 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US7981604B2 (en) 2004-02-19 2011-07-19 California Institute Of Technology Methods and kits for analyzing polynucleotide sequences
US9012144B2 (en) 2003-11-12 2015-04-21 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US9096898B2 (en) 1998-05-01 2015-08-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8814398U1 (fr) * 1988-11-17 1989-02-16 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De
WO1991007486A1 (fr) * 1989-11-17 1991-05-30 Stapleton Marilyn J Systeme pour le traitement d'echantillons biologiques pour l'analyse d'acides nucleiques
WO1993002212A1 (fr) * 1991-07-24 1993-02-04 University Partnerships Pty. Ltd. Amplification et sequençage d'acides nucleiques en une etape
WO1993022058A1 (fr) * 1992-05-01 1993-11-11 Trustees Of The University Of Pennsylvania Analyse par amplification de polynucleotide a l'aide d'un dispositif micro-fabrique
EP0572023A2 (fr) * 1992-05-29 1993-12-01 Shimadzu Corporation Appareil d'électrophorèse
WO1994005414A1 (fr) * 1992-08-31 1994-03-17 The Regents Of The University Of California Reacteur microfabrique
WO1994008234A1 (fr) * 1992-09-30 1994-04-14 Labintelligence, Inc. Dispositif d'application/de recuperation d'echantillon d'electrophorese sur gel
WO1996018892A1 (fr) * 1994-12-12 1996-06-20 Visible Genetics Inc. Appareil automatise d'electrophorese et de detection de la fluorescence et procede d'utilisation
WO1996035810A1 (fr) * 1995-05-09 1996-11-14 Curagen Corporation Appareil et procede permettant la production, la separation, la detection et l'identification de fragments de biopolymeres
WO1997041259A1 (fr) * 1996-05-01 1997-11-06 Visible Genetics Inc. Procede de sequencage de polymeres d'acide nucleique

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8814398U1 (fr) * 1988-11-17 1989-02-16 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De
WO1991007486A1 (fr) * 1989-11-17 1991-05-30 Stapleton Marilyn J Systeme pour le traitement d'echantillons biologiques pour l'analyse d'acides nucleiques
WO1993002212A1 (fr) * 1991-07-24 1993-02-04 University Partnerships Pty. Ltd. Amplification et sequençage d'acides nucleiques en une etape
WO1993022058A1 (fr) * 1992-05-01 1993-11-11 Trustees Of The University Of Pennsylvania Analyse par amplification de polynucleotide a l'aide d'un dispositif micro-fabrique
EP0572023A2 (fr) * 1992-05-29 1993-12-01 Shimadzu Corporation Appareil d'électrophorèse
WO1994005414A1 (fr) * 1992-08-31 1994-03-17 The Regents Of The University Of California Reacteur microfabrique
WO1994008234A1 (fr) * 1992-09-30 1994-04-14 Labintelligence, Inc. Dispositif d'application/de recuperation d'echantillon d'electrophorese sur gel
WO1996018892A1 (fr) * 1994-12-12 1996-06-20 Visible Genetics Inc. Appareil automatise d'electrophorese et de detection de la fluorescence et procede d'utilisation
WO1996035810A1 (fr) * 1995-05-09 1996-11-14 Curagen Corporation Appareil et procede permettant la production, la separation, la detection et l'identification de fragments de biopolymeres
WO1997041259A1 (fr) * 1996-05-01 1997-11-06 Visible Genetics Inc. Procede de sequencage de polymeres d'acide nucleique

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9540689B2 (en) 1998-05-01 2017-01-10 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9458500B2 (en) 1998-05-01 2016-10-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US10208341B2 (en) 1998-05-01 2019-02-19 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9957561B2 (en) 1998-05-01 2018-05-01 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9725764B2 (en) 1998-05-01 2017-08-08 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9096898B2 (en) 1998-05-01 2015-08-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US10214774B2 (en) 1998-05-01 2019-02-26 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9212393B2 (en) 1998-05-01 2015-12-15 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7645596B2 (en) 1998-05-01 2010-01-12 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
FR2795426A1 (fr) * 1999-06-22 2000-12-29 Commissariat Energie Atomique Support d'analyse biologique a amplification
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US9012144B2 (en) 2003-11-12 2015-04-21 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US9657344B2 (en) 2003-11-12 2017-05-23 Fluidigm Corporation Short cycle methods for sequencing polynucleotides
US7981604B2 (en) 2004-02-19 2011-07-19 California Institute Of Technology Methods and kits for analyzing polynucleotide sequences
US7967968B2 (en) 2004-03-15 2011-06-28 D.N.R.-Imaging Systems Ltd. Method and system for monitoring material separation process such as electrophoresis process in a sample
EP1733218A4 (fr) * 2004-03-15 2009-03-18 D N R Imaging Systems Ltd Procede et systeme pour controler un processus de separation des matieres tel qu'un processus d'electrophorese dans un echantillon
EP1733218A2 (fr) * 2004-03-15 2006-12-20 D.N.R. - Imaging Systems Ltd Procede et systeme pour controler un processus de separation des matieres tel qu'un processus d'electrophorese dans un echantillon
US7223949B2 (en) 2004-04-21 2007-05-29 Beckman Coulter, Inc. Analysis apparatus having improved temperature control unit
WO2005106449A1 (fr) * 2004-04-21 2005-11-10 Beckman Coulter, Inc. Dispositif d'analyse dote d'une unite de regulation de la temperature perfectionnee
US7600438B2 (en) 2004-09-30 2009-10-13 Roche Molecular Systems, Inc. Device and method for the adjustment of a temperature of a liquid
JP2006105990A (ja) * 2004-09-30 2006-04-20 F Hoffmann La Roche Ag 液体の温度を調節する装置および方法
EP1642648A1 (fr) * 2004-09-30 2006-04-05 Roche Diagnostics GmbH Dispositif et proeédé pour regler la temperature d'un liquide
EP1642647A1 (fr) * 2004-09-30 2006-04-05 Roche Diagnostics GmbH Dispositif et proeédé pour regler la temperature d'un liquide
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US9868978B2 (en) 2005-08-26 2018-01-16 Fluidigm Corporation Single molecule sequencing of captured nucleic acids

Also Published As

Publication number Publication date
CA2264961A1 (fr) 1998-03-05
EP0927268A1 (fr) 1999-07-07
AU4236597A (en) 1998-03-19

Similar Documents

Publication Publication Date Title
US7015030B1 (en) Microfluidic devices and uses thereof in biochemical processes
US6977145B2 (en) Method for carrying out a biochemical protocol in continuous flow in a microreactor
US5830657A (en) Method for single-tube sequencing of nucleic acid polymers
US5789168A (en) Method for amplification and sequencing of nucleic acid polymers
JP3909859B2 (ja) 中規模ポリヌクレオチド増幅装置
US20150217293A1 (en) Fluid Processing Device and Method
US20090325278A1 (en) Reaction System for Performing in the Amplification of Nucleic Acids
AU2002244899A1 (en) Method for carrying out a biochemical protocol in continuous flow in a microreactor
CA2372112A1 (fr) Pcr rapides inefficaces
JP2008500836A (ja) 微細加工集積ｄｎａ分析システム
US20050208539A1 (en) Quantitative amplification and detection of small numbers of target polynucleotides
WO2000009753A1 (fr) Sequençage d'adn par differenciation des periodes de decroissance d'emission de sondes fluorescentes et systemes a cet effet
EP2956550B1 (fr) Liaison améliorée d'une sonde
EP0927268A1 (fr) Appareil et procede pour la mise en oeuvre d'un sequen age de polymeres nucleotidiques
US5985555A (en) Method and apparatus for processing nucleic acids using a small temperature-changing zone
CA2490197A1 (fr) Appareil de detection et d'analyse quantitative de polynucleotides
JP3851672B2 (ja) Ｄｎａ増幅装置
US20010055772A1 (en) Pressure-controlled nucleic acid hybridization
US20120088234A1 (en) Device for performing pcrs
US20080032330A1 (en) Process for self-assembly of structures in a liquid
CN1190500C (zh) 分析核酸分子长度的方法
JP2001305105A (ja) 平板型ゲル電気泳動装置
JP2004298018A (ja) プローブ固相化反応アレイによる核酸の分離回収法
JP2001305106A (ja) Ｄｎａサンプルローディングツール
JP2004121226A (ja) ポリヌクレオチドの分析方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2264961

Country of ref document: CA

Ref country code: CA

Ref document number: 2264961

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997940630

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998511872

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997940630

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09242812

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1997940630

Country of ref document: EP